Board of Regents of the University of Nebraska — Omaha, Nebraska

Board of Regents of the University of Nebraska is a clinical research site located in Omaha, Nebraska, United States 68198-5450.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Board of Regents of the University of Nebraska has participated in 2 clinical trials.

Therapeutic areas: Hunter Syndrome, Stroke, Atrial Fibrillation.

Sponsors: Takeda, Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Board of Regents of the University of Nebraska?

Board of Regents of the University of Nebraska has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Board of Regents of the University of Nebraska conducted?

Board of Regents of the University of Nebraska has 2 clinical trials on record. Their work covers Hunter Syndrome, Stroke, Atrial Fibrillation.

Is Board of Regents of the University of Nebraska accredited by Crixeo Health?

Board of Regents of the University of Nebraska has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Board of Regents of the University of Nebraska?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.